Vasculitis Trial, Recruiting (NCT03004326)

Vasculitis Trial, Recruiting NCT03004326 Sponsor: Peter Merkel Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT03004326 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a skin lesion (such as spots, raised rashes, sores, bumps, or hives) that doctors believe is related to active vasculitis (inflammation of the blood vessels)
You have a suspected or confirmed diagnosis of one of the following conditions: Cryoglobulinemic vasculitis, Drug-induced vasculitis, Eosinophilic granulomatosis with polyangiitis (EGPA), IgA vasculitis, Isolated cutaneous vasculitis, Granulomatosis with polyangiitis (GPA), Microscopic polyangiitis (MPA), Polyarteritis nodosa (PAN), or Urticarial vasculitis
You are willing and able to sign a consent form agreeing to take part (or, if you are a minor, a parent or guardian can sign on your behalf)

Who may not be able to join:

You are younger than five years old
Your doctor does not think you are a safe candidate for a skin biopsy (a small tissue sample), or believes the risks of the biopsy outweigh the potential benefits for you
Your blood test results show low levels of certain blood cells — specifically, too few white blood cells, too few platelets, or too little hemoglobin (confirm with trial site)
You have another serious, uncontrolled illness that could stop you from completing the study procedures
You have an active infection at or near the area where the biopsy would be done, poor blood circulation in that area, or a physical feature such as a bony area that could increase your risk of complications
You are currently pregnant or breastfeeding
You are unable to give your own informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03004326

Sponsor: Peter Merkel

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

More information: https://clinicaltrials.gov/study/NCT03004326

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a skin lesion (such as spots, raised rashes, sores, bumps, or hives) that doctors believe is related to active vasculitis (inflammation of the blood vessels)
You have a suspected or confirmed diagnosis of one of the following conditions: Cryoglobulinemic vasculitis, Drug-induced vasculitis, Eosinophilic granulomatosis with polyangiitis (EGPA), IgA vasculitis, Isolated cutaneous vasculitis, Granulomatosis with polyangiitis (GPA), Microscopic polyangiitis (MPA), Polyarteritis nodosa (PAN), or Urticarial vasculitis
You are willing and able to sign a consent form agreeing to take part (or, if you are a minor, a parent or guardian can sign on your behalf)

Who may not be able to join:

You are younger than five years old
Your doctor does not think you are a safe candidate for a skin biopsy (a small tissue sample), or believes the risks of the biopsy outweigh the potential benefits for you
Your blood test results show low levels of certain blood cells — specifically, too few white blood cells, too few platelets, or too little hemoglobin (confirm with trial site)
You have another serious, uncontrolled illness that could stop you from completing the study procedures
You have an active infection at or near the area where the biopsy would be done, poor blood circulation in that area, or a physical feature such as a bony area that could increase your risk of complications
You are currently pregnant or breastfeeding
You are unable to give your own informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peter Merkel

Registry

ClinicalTrials.gov

Start date

1 January 2017

Est. completion

1 December 2028

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Evaluation of clinical data and linked biopsy specimens

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov